相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Peng Guo et al.
SCIENCE ADVANCES (2019)
Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy
Peng Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
Ling Li et al.
BIOMATERIALS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines
P. Guo et al.
NANO LETTERS (2018)
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
Hong-Xia Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Nanoparticle elasticity directs tumor uptake
Peng Guo et al.
NATURE COMMUNICATIONS (2018)
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
Qiyi Feng et al.
SCIENTIFIC REPORTS (2018)
Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C+ monocytes
Li Liu et al.
THERANOSTICS (2018)
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn et al.
CELL REPORTS (2018)
A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
Jing Huang et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
Roselena Silvestri Schuh et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
Jie Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?
Brigitte Bauvois et al.
CANCERS (2018)
Delivery technologies for genome editing
Hao Yin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Characterization of Dormant and Active Human Cancer Cells by Quantitative Phase Imaging
Peng Guo et al.
CYTOMETRY PART A (2017)
Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence
Laura Roli et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
Hao Yin et al.
NATURE BIOTECHNOLOGY (2016)
Applications of CRISPR technologies in research and beyond
Rodolphe Barrangou et al.
NATURE BIOTECHNOLOGY (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Microfluidic Synthesis of Hybrid Nanoparticles with Controlled Lipid Layers: Understanding Flexibility-Regulated Cell-Nanoparticle Interaction
Lu Zhang et al.
ACS NANO (2015)
Biomedical applications of hydrogels: A review of patents and commercial products
Enrica Calo et al.
EUROPEAN POLYMER JOURNAL (2015)
Tunable Rigidity of (Polymeric Core)-(Lipid Shell) Nanoparticles for Regulated Cellular Uptake
Jiashu Sun et al.
ADVANCED MATERIALS (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
John A. Zuris et al.
NATURE BIOTECHNOLOGY (2015)
HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2
Guangcun Cheng et al.
CANCER RESEARCH (2014)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
ICAM-1 as a molecular target for triple negative breast cancer
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
Saverio Candido et al.
ONCOTARGET (2014)
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
Alessandro Parodi et al.
NATURE NANOTECHNOLOGY (2013)
Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry
Sandra Vranic et al.
PARTICLE AND FIBRE TOXICOLOGY (2013)
Effect of Aspect Ratio and Deformability on Nanoparticle Extravasation through Nanopores
Farrell R. Kersey et al.
LANGMUIR (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
Alginate: Properties and biomedical applications
Kuen Yong Lee et al.
PROGRESS IN POLYMER SCIENCE (2012)
Relationships of Lipocalin 2 With Breast Tumorigenesis and Metastasis
Xiaohong Leng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Lipocalin 2 A multifaceted modulator of human cancer
Jiang Yang et al.
CELL CYCLE (2009)
Lipocalin 2 promotes breast cancer progression
Jiang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
Maret Bauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
分享论文
